Armignacco, Roberta
Carlier, Nicolas
Jouinot, Anne
Birtolo, Maria Francesca
de Murat, Daniel
Tubach, Florence
Hausfater, Pierre
Simon, Tabassome
Gorochov, Guy
Pourcher, Valérie
Beurton, Alexandra
Goulet, Hélène
Manivet, Philippe
Bertherat, Jérôme
Assié, Guillaume
,
Article History
Received: 26 February 2024
Revised: 11 April 2024
Accepted: 12 April 2024
First Online: 21 May 2024
Declarations
:
: The COVIDeF cohort Study is registered at ClinicalTrials.gov (NCT04352348; date of trial registration: 20/04/2020), ethics approval was obtained from the Comité de Protection des Personnes Ile de France XI (ID RCB, 2020-A00754-35). The sponsor is the Direction de la Recherche Clinique de l’Assistance Publique des Hôpitaux de Paris (DRCI de l’APHP).All methods were performed in accordance with the relevant guidelines and regulations.
: Signed informed consent for molecular analysis of blood samples and for access to clinical data was obtained from all patients, and the study was approved by the Ethic Committee.
: The authors declare no competing interests.